M&A Due Diligence in Asian Insurance Markets: What Buyers Need to Know

Why Insurance M&A Due Diligence Is Different

Acquiring a company in any sector requires financial, legal and operational due diligence. In insurance, those standard workstreams are joined by several that are sector-specific and require specialist expertise: actuarial due diligence of the insurance liabilities, regulatory due diligence of the licences and compliance history, and an assessment of the reinsurance programme and its recoverability.

These additional workstreams are not peripheral. The actuarial liabilities are often the largest item on the balance sheet, and their adequacy depends on assumptions that require specialist review. The regulatory licences are the commercial foundation of the business, and their status -- including any conditions, restrictions or informal supervisory concerns -- directly affects the value of what is being acquired. A deal that discovers post-closing that the reserves were inadequate or that the regulator had concerns about the business can result in losses that dwarf the cost of proper pre-closing due diligence.

Regulatory Due Diligence

For any insurer or insurance intermediary in Asia Pacific, the regulatory due diligence is a foundational workstream. The questions it addresses go well beyond confirming that the entity is licensed.

Licence scope and conditions: The licence of an insurance company or intermediary defines what products it can offer, what markets it can serve and sometimes what distribution channels it can use. A licence that appears clean may carry informal conditions arising from supervisory dialogue that are not documented in the licence itself. Understanding the full scope of what the regulator has said about the entity's operations requires reviewing supervisory correspondence, not just the licence document.

MAS regulatory history: In Singapore, MAS maintains supervisory relationships with licensed entities that extend well beyond formal regulatory actions. An insurer may have received feedback through examination reports, thematic reviews or supervisory dialogue that has not been publicly disclosed but that reflects concerns about its governance, risk management or compliance. Access to this history -- through management interviews and document review -- is essential for understanding the regulatory risk in the transaction.

Change-of-control approvals: In Singapore, acquiring a substantial shareholding in a licensed insurer or financial adviser requires MAS approval. This creates a regulatory condition that must be satisfied before the transaction can close and introduces regulatory timeline risk. The MAS approval process is not automatic; it requires the acquirer to demonstrate that it meets the fit-and-proper standards for controlling shareholders and that the acquisition will not adversely affect the licensee. In other markets, similar requirements apply under OJK in Indonesia, BNM in Malaysia and the respective regulators in other jurisdictions.

Compliance history: A review of the target's compliance history -- including any sanctions, warnings, fines or enforcement actions in any market -- is standard due diligence but requires more depth in a regulated entity than in a non-regulated one. Insurance intermediaries in particular have varied compliance records, and the conduct history of key individuals is relevant both to regulatory approval of the transaction and to the post-closing management of the business.

Actuarial Due Diligence

The insurance liabilities on the balance sheet are typically the most significant item for an insurer and often for an intermediary holding run-off obligations. Actuarial due diligence assesses whether those liabilities are adequately provisioned and identifies the risks that could cause them to be higher than stated.

Reserve adequacy assessment: The independent actuary conducting due diligence reviews the management's reserve estimates against their own assessment of appropriate reserve levels. This involves reviewing the claims data, the reserving methodology, the assumptions used and the sensitivity of the reserves to those assumptions. For long-tail lines -- liability, workers' compensation, professional indemnity -- the uncertainty in reserve estimates is wider and the due diligence work is correspondingly more intensive.

Pricing and product profitability: For a going-concern insurer, the profitability of the current book and new business being written is as important as the adequacy of legacy reserves. Due diligence should include an assessment of the pricing adequacy of current products and the trend in loss ratios and combined ratios over the historical period.

Embedded value and value of in-force business: For a life insurer, the embedded value or value of in-force business is a central metric for valuation. The assumptions embedded in the embedded value calculation -- investment returns, mortality, morbidity, lapse rates, expense assumptions -- should all be scrutinised in due diligence. The sensitivity of the embedded value to changes in those assumptions defines the range of outcomes the acquirer should model.

IFRS 17 implications: For insurers reporting under IFRS 17, the due diligence needs to engage with the IFRS 17 accounting model as well as the regulatory solvency position. The Contractual Service Margin, the risk adjustment and the discount rate assumptions all affect the IFRS 17 balance sheet in ways that the acquirer needs to understand before completing the transaction.

Reinsurance Programme Assessment

The reinsurance programme of the target insurer is both a risk management tool and a balance sheet asset. Due diligence should assess both dimensions.

Programme structure and adequacy: Does the reinsurance programme provide the protection that the business needs given its risk profile? Are there gaps in coverage, limitations or exclusions that create retained exposure that is not visible from the balance sheet alone?

Counterparty credit quality: The reinsurance recoverables on the balance sheet are only as valuable as the ability to collect them from reinsurers. The credit quality of the reinsurer panel, the concentration of exposure to individual reinsurers and the collateral arrangements supporting uncollateralised recoverables all need to be assessed.

Run-off recoverables: Legacy reinsurance recoverables from prior years may carry collection risk if reinsurers have been restructured, are in run-off, or are disputing coverage. An insurer with significant aged recoverables needs careful assessment of their recoverability.

Operational and Financial Due Diligence

Beyond the sector-specific workstreams, insurance M&A due diligence includes the standard financial and operational work.

Financial due diligence reviews the historical financial statements for accuracy and sustainability, assesses the quality of earnings, and builds the financial model for the transaction. For an insurer, the interaction between IFRS 17, statutory solvency reporting and management accounts creates a multi-framework environment that requires care in reconciliation.

Distribution due diligence for a going-concern insurer or intermediary is often as important as the balance sheet. The distribution agreements, agent network, bancassurance partnerships or direct channels that generate new business are the commercial engine of the company. The quality, exclusivity and transferability of those relationships determine what the acquirer is actually buying.

Technology and data due diligence has become increasingly important as insurance companies modernise their technology stacks. Legacy policy administration systems are a common source of post-acquisition cost and operational risk. Understanding the state of the technology estate and the cost of any required modernisation is essential for accurate pricing.

People and talent: In insurance, key individuals often carry significant client relationships, actuarial expertise or regulatory relationships that are difficult to replace. Identifying key persons and assessing retention risk is standard in any acquisition but particularly important in professional services-intensive insurance businesses.

Valuation Considerations

Insurance company valuation uses methodologies that differ from those used for non-financial companies. Discounted cash flow analysis and comparable company multiples are both used, but for life insurers the embedded value approach is often the primary valuation framework. For general insurers, price-to-book and price-to-earnings multiples relative to regional comparables are commonly used.

The interaction between valuation methodology and due diligence findings matters. If actuarial due diligence identifies that reserves should be higher, or if regulatory due diligence identifies a risk that affects future profitability, those findings need to flow through to the valuation model. Due diligence that produces findings that are then not properly integrated into pricing is a recurring weakness in transactions that encounter post-closing surprises.

We advise buyers, sellers and investors on due diligence and corporate deals across Asia Pacific insurance and financial services transactions, including actuarial due diligence, regulatory assessment and financial modelling. For transactions with market entry or licensing dimensions, our market entry advisory practice works alongside the transaction team. If you are assessing an acquisition target or preparing a business for sale in the Asian insurance market, our team is available to discuss your specific position.